Maastricht University-ko ikertzaileekin lankidetzan egindako argitalpenak (27)

2024

  1. The prevalence of feigning and concealment of Covid-19 infections in an international sample

    Journal of Health Psychology, Vol. 29, Núm. 6, pp. 595-607

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  3. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14

  4. Taxation of Payments for the Acquisition of Software for Business Use for Spanish Treaty Purposes: Standard Software versus Customized Software and the Spanish Observation to the Commentary on Article 12 of the OECD Model

    Bulletin for International Taxation, Vol. 77, Núm. 4, pp. 168-176

  5. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

  6. Tobacco use in first-episode psychosis, a multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276

2022

  1. A replication study of JTC bias, genetic liability for psychosis and delusional ideation

    Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783

  2. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

    Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922

  3. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113

  4. The Self-Report Symptom Inventory

    Psychological Injury and Law, Vol. 15, Núm. 1, pp. 94-103

  5. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    European Neuropsychopharmacology, Vol. 63, pp. 47-59

  6. The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review

    Neuroscience and Biobehavioral Reviews, Vol. 143

  7. Tracking critical power using maximal mean power outputs during short, medium, and long intervals in well-trained cyclists

    Medicina dello Sport, Vol. 75, Núm. 1, pp. 5-15

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

  3. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

    Schizophrenia Research, Vol. 236, pp. 69-79

  4. Transdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes

    Nutrients, Vol. 13, Núm. 12

2020

  1. Effects of Body Weight vs. Lean Body Mass on Wingate Anaerobic Test Performance in Endurance Athletes

    International journal of sports medicine, Vol. 41, Núm. 8, pp. 545-551

  2. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

    Epidemiology and Psychiatric Sciences